Skip to main content
. 2020 Jun 2;11(3):e00465-20. doi: 10.1128/mBio.00465-20

TABLE 3.

MIC of various compounds against Salmonella Typhimurium SL1344 ramR::aph, Escherichia coli BW25113 marR::aph, Acinetobacter baumannii AB211, and Pseudomonas aeruginosa PAO1 exposed to various compounds alone and in combination with chlorpromazine

Antibiotics Chlorpromazine concn (fraction of MIC) MIC (μg/ml)a
SL1344 ramR::aph BW25113 marR::aph AB211 PAO1
Chloramphenicol None 8 4 64 128
1/16 4 2 64 64
1/8 2 2 64 32
1/4 1 2 32 32
Ciprofloxacin None 0.03 0.008 128 0.25
1/16 0.03 0.008 128 0.25
1/8 0.015 0.008 128 0.25
1/4 0.008 0.004 128 0.25
Nalidixic acid None 8 4 512 512
1/16 4 2 512 128
1/8 4 2 512 128
1/4 0.5 2 512 64
Tetracycline None 4 2 512 32
1/16 4 1 512 16
1/8 2 1 256 8
1/4 1 1 256 8
Norfloxacin None 0.25 0.03 256 1
1/16 0.25 0.03 512 1
1/8 0.25 0.06 512 1
1/4 0.5 0.06 256 1
Ethidium bromide None 1,024 128 128 4,096
1/16 512 128 64 1,024
1/8 512 64 64 1,024
1/4 512 64 64 256
a

The MIC of chlorpromazine was 1,024 μg/ml, 256 μg/ml, 128 μg/ml, and 2,048 μg/ml against SL1344 ramR::aph, BW25113 marR::aph, AB211, and PAO1, respectively. Bold font indicates a ≥2-fold decrease in MIC value in comparison to the antibiotic alone.